Risk factors of brain metastases as initial failure in completely resected stage IIIA(N2) non-small cell lung cancer

por Zhang, Qin, Cai, Xu-Wei, Feng, Wen, Yu, Wen, Fu, Xiao-Long
Publicado 2020

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer

por Zhang, Qin, Cai, Xu-Wei, Feng, Wen, Yu, Wen, Fu, Xiao-Long
Publicado 2022

Tolerance and dose-volume relationship of intrathoracic stomach irradiation after esophagectomy for patients with thoracic esophageal squamous cell carcinoma

por Liu, Qi, Cai, Xu-Wei, Fu, Xiao-Long, Chen, Jun-Chao, Xiang, Jia-Qing
Publicado 2015

Patterns of Failure after Radical Surgery among Patients with Thoracic Esophageal Squamous Cell Carcinoma: Implications for the Clinical Target Volume Design of Postoperative Radio...

por Liu, Qi, Cai, Xu-Wei, Wu, Bin, Zhu, Zheng-Fei, Chen, Hai-Quan, Fu, Xiao-Long
Publicado 2014

The positive role of vitronectin in radiation induced lung toxicity: the in vitro and in vivo mechanism study

por Shen, Tian-Le, Liu, Mi-Na, Zhang, Qin, Feng, Wen, Yu, Wen, Fu, Xiao-Long, Cai, Xu-Wei
Publicado 2018

Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review

por Xia, Wu-Yan, Feng, Wen, Zhang, Chen-Chen, Shen, Yu-Jia, Zhang, Qin, Yu, Wen, Cai, Xu-Wei, Fu, Xiao-Long
Publicado 2020

The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer

por Xia, Bing, Chen, Gui-Yuan, Cai, Xu-Wei, Zhao, Jian-Dong, Yang, Huan-Jun, Fan, Min, Zhao, Kuai-Le, Fu, Xiao-Long
Publicado 2011

Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach

por Feng, Wen, Li, Yuan, Shen, Lei, Zhang, Qin, Cai, Xu-Wei, Zhu, Zheng-Fei, Sun, Meng-Hong, Chen, Hai-Quan, Fu, Xiao-Long
Publicado 2021

Radiomics Signature Facilitates Organ-Saving Strategy in Patients With Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy

por Li, Yue, Liu, Jun, Li, Hong-xuan, Cai, Xu-wei, Li, Zhi-gang, Ye, Xiao-dan, Teng, Hao-hua, Fu, Xiao-long, Yu, Wen
Publicado 2021

The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and insti...

por Feng, Wen, Zhang, Qin, Fu, Xiao-Long, Cai, Xu-Wei, Zhu, Zheng-Fei, Yang, Huan-Jun, Xiang, Jia-Qing, Zhang, Ya-Wei, Chen, Hai-Quan
Publicado 2015

Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophy...

por Zhao, Lei, Shen, Yan, Guo, Jin-Dong, Gu, Heng-Le, Yu, Wen, Wang, Jia-Ming, LV, Chang-Xing, Liu, Jun, Cai, Xu-Wei, Fu, Xiao-Long
Publicado 2017

Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer...

por Xia, Wu-Yan, Zhu, Xue-Ru, Feng, Wen, Liu, Jun, Wang, Jia-Ming, Lv, Chang-Xing, Zhang, Qin, Yu, Wen, Cai, Xu-Wei, Fu, Xiao-Long
Publicado 2020

Enhancing Prediction for Tumor Pathologic Response to Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Cancer by Dynamic Parameters from Clinical Assessments

por Song, Xin-Yun, Liu, Jun, Li, Hong-Xuan, Cai, Xu-Wei, Li, Zhi-Gang, Su, Yu-Chen, Li, Yue, Dong, Xiao-Huan, Yu, Wen, Fu, Xiao-Long
Publicado 2023

Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer

por Feng, Wen, Li, Yuan, Shen, Lei, Cai, Xu-Wei, Zhu, Zheng-Fei, Chang, Jian-Hua, Xiang, Jia-Qing, Zhang, Ya-Wei, Chen, Hai-Quan, Fu, Xiao-Long
Publicado 2016

Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma

por Cai, Xu‐Wei, Yu, Wei‐Wei, Yu, Wen, Zhang, Qin, Feng, Wen, Liu, Mi‐Na, Sun, Meng‐Hong, Xiang, Jia‐Qing, Zhang, Ya‐Wei, Fu, Xiao‐Long
Publicado 2018

Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy

por Zeng, Ya, Yu, Wen, Liu, Qi, Yu, Wei-Wei, Zhu, Zheng-Fei, Zhao, Wei-Xin, Liu, Jun, Wang, Jia-Ming, Fu, Xiao-Long, Liu, Yuan, Cai, Xu-Wei
Publicado 2019

Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy

por Yang, Zhang-Ru, Liu, Mi-Na, Yu, Jia-Hua, Yang, Yun-Hai, Chen, Tian-Xiang, Han, Yu-Chen, Zhu, Lei, Zhao, Ji-Kai, Fu, Xiao-Long, Cai, Xu-Wei
Publicado 2020

PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells

por Zhao, Xin-min, Pan, Shi-yun, Huang, Qi-ling, Lu, You-ni, Wu, Xiang-hua, Chang, Jian-Hua, Liu, Zhe-Bin, Cai, Xu-Wei, Liu, Qi, Wang, Jia-lei, Fu, Xiao-Long
Publicado 2016

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection

por Shen, Yu-Jia, Qian, Li-Qiang, Ding, Zheng-Ping, Luo, Qing-Quan, Zhao, Heng, Xia, Wu-Yan, Fu, Yuan-Yuan, Feng, Wen, Zhang, Qin, Yu, Wen, Cai, Xu-Wei, Fu, Xiao-Long
Publicado 2021

EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma

por Xiang, Chan, Zhang, Wei, Xiong, Li-Wen, Cai, Xu-Wei, Teng, Hao-Hua, Zhao, Rui-Ying, Shang, Zhan-Xian, Han-Zhang, Han, Zhang, Lu, Yan, Li, Chen, Zhi-Qiu, Han, Yu-Chen
Publicado 2021